Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I S Chen

Showing results (71-80 of 205) with videos related to

Pageof 21
Sort By:
Journal of Virology|June 14, 2000
Enhanced binding of antibodies to neutralization epitopes following thermal and chemical inactivation of human immunodeficiency virus type 1K Grovit-Ferbas, J F Hsu, J Ferbas, et al.
Journal of Virology|August 3, 2001
Antibody-directed targeting of retroviral vectors via cell surface antigensK Morizono, G Bristol, Y M Xie, et al.
Science (New York, N.Y.)|October 12, 1984
Expression of the 3' terminal region of human T-cell leukemia virusesW Wachsman, K Shimotohno, S C Clark, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic diseaseS Pang, H V Vinters, T Akashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cellsS A Stewart, B Poon, J B Jowett, et al.
Journal of Virology|August 17, 2001
A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infectionM A Poles, J Elliott, P Taing, et al.
Journal of Virology|April 1, 1992
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1J E Merrill, Y Koyanagi, J Zack, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1997
Antitumor agents. 168. Dysoxylum cumingianum. IV. The structures of cumingianosides G-O, new triterpene glucosides with a 14,18-cycloapotirucallane-type skeleton from Dysoxylum cumingianum, and their cytotoxicity against human cancer cell linesT Fujioka, A Sakurai, K Mihashi, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1997
Antitumor agents. 169 Dysoxylum cumingianum. V. Cumingianosides P and Q, new cytotoxic triterpene glucosides with an apotirucallane-type skeleton from Dysoxylum cumingianumT Fujioka, A Sakurai, K Mihashi, et al.
Nature|October 6, 1983
Molecular characterization of genome of a novel human T-cell leukaemia virusI S Chen, J McLaughlin, J C Gasson, et al.
Pageof 21

Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
Journal of Virology|June 14, 2000
Enhanced binding of antibodies to neutralization epitopes following thermal and chemical inactivation of human immunodeficiency virus type 1K Grovit-Ferbas, J F Hsu, J Ferbas, et al.
Journal of Virology|August 3, 2001
Antibody-directed targeting of retroviral vectors via cell surface antigensK Morizono, G Bristol, Y M Xie, et al.
Science (New York, N.Y.)|October 12, 1984
Expression of the 3' terminal region of human T-cell leukemia virusesW Wachsman, K Shimotohno, S C Clark, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic diseaseS Pang, H V Vinters, T Akashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cellsS A Stewart, B Poon, J B Jowett, et al.
Journal of Virology|August 17, 2001
A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infectionM A Poles, J Elliott, P Taing, et al.
Journal of Virology|April 1, 1992
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1J E Merrill, Y Koyanagi, J Zack, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1997
Antitumor agents. 168. Dysoxylum cumingianum. IV. The structures of cumingianosides G-O, new triterpene glucosides with a 14,18-cycloapotirucallane-type skeleton from Dysoxylum cumingianum, and their cytotoxicity against human cancer cell linesT Fujioka, A Sakurai, K Mihashi, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1997
Antitumor agents. 169 Dysoxylum cumingianum. V. Cumingianosides P and Q, new cytotoxic triterpene glucosides with an apotirucallane-type skeleton from Dysoxylum cumingianumT Fujioka, A Sakurai, K Mihashi, et al.
Nature|October 6, 1983
Molecular characterization of genome of a novel human T-cell leukaemia virusI S Chen, J McLaughlin, J C Gasson, et al.
Pageof 21